Early Access Programs

Access to medicinal products before marketing approval

Helsinn’s Early Access Programs (EAP) allow patients with life threatening conditions access to cancer therapeutic products they would not otherwise have had access to.

Learn More
Educational Grants

Supporting legitimate and independent educational activities

Helsinn is committed to funding programs that communicate relevant scientific information to the medical community with the overall aim of improving patient care.

Learn More